Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
RRM1
Description:
RRM1 is a human protein-coding gene associated with ribonucleotide metabolism and studied as a biomarker in cancer biology and treatment.
Related topics:
Lung Cancer Treatments and Mutations (19%),
Pancreatic and Hepatic Oncology Research (9%),
RNA Research and Splicing (8%)
Wikidata ID:
wiki/Q18031326
OpenAlex ID:
keywords/rrm1
DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer
2007
·
Zhong Zheng
, Tingan Chen
, et al.
·
New England Journal of Medicine
·
466
PDF
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
2007
·
Y Nakano
, S Tanno
, et al.
·
British Journal of Cancer
·
338
PDF
RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer
2006
·
Gerold Bepler
, Irina Kusmartseva
, et al.
·
Journal of Clinical Oncology
·
336
PDF
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
2006
·
P. Ceppi
, M. Volante
, et al.
·
Annals of Oncology
·
328
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
2007
·
J. Bellmunt
, L. Paz-Ares
, et al.
·
Annals of Oncology
·
325
PDF
Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer
2004
·
D. Isla
, C. Sarries
, et al.
·
Annals of Oncology
·
292
An Increase in the Expression of Ribonucleotide Reductase Large Subunit 1 Is Associated with Gemcitabine Resistance in Non-Small Cell Lung Cancer Cell Lines
2004
·
Jennifer D. Davidson
, Liandong Ma
, et al.
·
Cancer Research
·
286
Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
2012
·
Raphaël Maréchal
, Jean–Baptiste Bachet
, et al.
·
Gastroenterology
·
245
PDF
Individual RNA Recognition Motifs of TIA-1 and TIAR Have Different RNA Binding Specificities
1996
·
Laura M. Dember
, Nancy D. Kim
, et al.
·
Journal of Biological Chemistry
·
233
PDF
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
2006
·
Shin Nakahira
, Shoji Nakamori
, et al.
·
International Journal of Cancer
·
223
PDF
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer
2003
·
Rafael Rosell
, Giorgio Scagliotti
, et al.
·
Oncogene
·
193
In vivo Induction of Resistance to Gemcitabine Results in Increased Expression of Ribonucleotide Reductase Subunit M1 as the Major Determinant
2005
·
Andries M. Bergman
, Paul P. Eijk
, et al.
·
Cancer Research
·
191
PDF
RRM1 and PTEN As Prognostic Parameters for Overall and Disease-Free Survival in Patients With Non–Small-Cell Lung Cancer
2004
·
Gerold Bepler
, Swati Sharma
, et al.
·
Journal of Clinical Oncology
·
184
Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy in Advanced Non–Small-Cell Lung Cancer
2007
·
George Simon
, Anupama Sharma
, et al.
·
Journal of Clinical Oncology
·
182
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer
2010
·
David J. Stewart
·
Critical Reviews in Oncology/Hematology
·
177
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer
2009
·
Craig Reynolds
, Coleman Obasaju
, et al.
·
Journal of Clinical Oncology
·
172
PDF
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
2010
·
Lars Petter Jordheim
, Pascal Sève
, et al.
·
The Lancet Oncology
·
170
Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
2010
·
Hayato Fujita
, Kenoki Ohuchida
, et al.
·
Neoplasia
·
160
PDF
Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response
2009
·
Yong-Wei Zhang
, Tamara L. Jones
, et al.
·
Journal of Biological Chemistry
·
150
PDF
RRM1-induced metastasis suppression through PTEN-regulated pathways
2003
·
Ashish Gautam
, Zhan-Rong Li
, et al.
·
Oncogene
·
146
Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer
2013
·
Gerold Bepler
, Charles Williams
, et al.
·
Journal of Clinical Oncology
·
143
Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase
2010
·
Hiroyuki Niida
, Yuko Katsuno
, et al.
·
Genes & Development
·
141
PDF
Identification of Molecular Vulnerabilities in Human Multiple Myeloma Cells by RNA Interference Lethality Screening of the Druggable Genome
2011
·
Rodger E. Tiedemann
, Yuan Xao Zhu
, et al.
·
Cancer Research
·
139
The THAP–zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes
2006
·
Corinne Cayrol
, Chrystelle Lacroix
, et al.
·
Blood
·
136
Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery
2004
·
Rafael Rosell
, Enriqueta Felip
, et al.
·
Clinical Cancer Research
·
131
Show more works
View as search
Works count:
1,169
Citation count:
19,490
Year
Topic
Type